LPS, mevastatin, and FITC-CTB were purchased from MilliporeSigma. Chloroquine, PSC-833, and 2‑hydroxypropyl-βCD were purchased from GE Healthcare (now Cytiva), Valspodar, and InvivoGen, respectively. PRX consisting of 2-(2-hydroxyethoxy) ethyl carbamate–modified βCDs as cyclic molecules, Pluronic P123 as an axle polymer, and N-triphenylmethyl groups as acid-cleavable stopper molecules were synthesized as described previously (45 (link), 46 (link)). The antibodies used were anti-Flag (catalog F1804; MilliporeSigma), anti-GST (PM013; MBL), anti-CFP (D153-3; MBL), anti-Myd88 (sc-74532; Santa Cruz Biotechnology), anti-p65 (sc-372; Santa Cruz Biotechnology), anti-GAPDH (ab181602; Abcam), anti-LAMP1 (sc-20011; Santa Cruz Biotechnology), anti-Rab7 (9367), anti-EE1A (3288; Cell Signaling Technology), anti-PDI (3501; Cell Signaling Technology), anti-Lamin A/C (4777; Cell Signaling Technology), and anti-CTB (SAB4200844; MilliporeSigma).
Free full text: Click here